Example: Heart Attack

Search clinical trials for: Gemfibrozil

Total 31 results

NCT02638597

Completed

Gemfibrozil for Nicotine Smoking Cessation

Conditions: Smoking Cessation
NCT01876810

Completed

Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction

Conditions: Nicotine Dependence
NCT01385020

Completed

Effect of Gemfibrozil on the Safety and Pharmacokinetics of Red Yeast Rice in Healthy Subjects

Conditions: Healthy Subjects
NCT03539432

Terminated

Exploration of Gemfibrozil as a Treatment for AUD

Conditions: Alcohol Use Disorder
NCT00474201

Completed

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Conditions: Healthy Volunteers
NCT02045056

Completed

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

Conditions: Preclinical Alzheimer's Disease
NCT00566865

Completed

Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil

Conditions: Type 2 Diabetes Mellitus
NCT00966966

Completed

Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered

Conditions: Healthy
NCT00800475

Completed

Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets

Conditions: Bioavailability
NCT01083212

Completed

To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656

Conditions: Type 2 Diabetes Mellitus
NCT01301742

Completed

Relative Bioavailability of Single Dose Empagliflozin (BI 10773) When Co-administered With Multiple Doses of 600 mg Gemfibrozil Compared to Single Dose Treatment With Empagliflozin (BI 10773) When Given Alone in Healthy Volunteers

Conditions: Healthy
NCT02230033

Completed

Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927

Conditions: Healthy
NCT00108511

Completed

Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides

Conditions: Hypertriglyceridemia
NCT01376232

Completed

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)

Conditions: Anaemia
NCT01736254

Completed

A Study of Evacetrapib in Healthy Participants

Conditions: Healthy Volunteers
NCT01913379

Completed

Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole

Conditions: Healthy Subjects; Pharmacokinetics; Drug-Drug Interaction
NCT02770222

Completed

A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects

Conditions: Healthy Subjects
NCT01797198

Completed

A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects

Conditions: Drug-Drug Interaction (DDI); Healthy Subjects
NCT00283335

Completed

The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol

Conditions: Coronary Heart Disease
NCT01836198

Completed

The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream

Conditions: Healthy Volunteers
NCT01340846

Completed

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Conditions: Cancer
NCT00243672

Withdrawn

Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques

Conditions: Atherosclerosis
NCT03624959

Completed

Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A

Conditions: Healthy Volunteer
NCT00039663

Completed

Endothelial Dysfunction as a Risk Factor in HIV Study

Conditions: HIV Infections
NCT04008186

Completed

A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

Conditions: Healthy Adult Subjects